Murine-Derived Monoclonal Antibodies

Antibodies obtained from a single clone of cells grown in mice or rats.

Also Known As:

Antibodies, Monoclonal, Murine-Derived; Antibodies, Murine-Derived Monoclonal; Monoclonal Antibodies, Murine-Derived; Murine Derived Monoclonal Antibodies

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Murine-Derived Monoclonal Antibodies: 1
        Rituximab: 15450
        Muromonab-CD3: 726
        Edrecolomab: 131
        anti-Fas monoclonal antibody: 49
        monoclonal antibody D2-40: 44
        Sulesomab: 38
        CT-P10: 29
        MOv18 monoclonal antibody: 28
        oregovomab: 28
        abagovomab: 22
        racotumomab: 18
        besilesomab: 9
        enlimomab: 8
        Lym-1 monoclonal antibody: 8
        8H9 monoclonal antibody: 7
        omburtamab I-131: 7
        3F8 antibody: 4
        64Cu-DOTA-rituximab: 4
        PR1A3 monoclonal antibody: 4
        12C3 monoclonal antibody: 3
        PF-06647263: 2
        23C3 monoclonal antibody: 1
        3D6 antibody: 1
        CD44 monoclonal antibody KMP1: 1
        MX 35 monoclonal antibody: 1
        RG 83852 monoclonal antibody: 1
        technetium Tc 99m CIBCNSH3: 1
        technetium Tc 99m-nofetumomab merpentan: 1
        TOL-101: 1
        9F7-F11 antibody
        AC12 monoclonal antibody
        EP-5C7 monoclonal antibody
        K7153A
        LBY135 monoclonal antibody
        M290SAP
        Mab13-1 monoclonal antibody
        monoclonal antibody 2P-1-2-1
        monoclonal antibody B23 heavy chain
        R21 monoclonal antibody
        RCK105
        RIME regimen
        technetium 99m rituximab
        technetium Tc 99m-monoclonal antibody-170H.82
        TSK114 monoclonal antibody
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Murine-Derived Monoclonal Antibodies: 1
        Rituximab: 15450
        Muromonab-CD3: 726
        Edrecolomab: 131
        anti-Fas monoclonal antibody: 49
        monoclonal antibody D2-40: 44
        Sulesomab: 38
        CT-P10: 29
        MOv18 monoclonal antibody: 28
        oregovomab: 28
        abagovomab: 22
        racotumomab: 18
        besilesomab: 9
        enlimomab: 8
        Lym-1 monoclonal antibody: 8
        8H9 monoclonal antibody: 7
        omburtamab I-131: 7
        3F8 antibody: 4
        64Cu-DOTA-rituximab: 4
        PR1A3 monoclonal antibody: 4
        12C3 monoclonal antibody: 3
        PF-06647263: 2
        23C3 monoclonal antibody: 1
        3D6 antibody: 1
        CD44 monoclonal antibody KMP1: 1
        MX 35 monoclonal antibody: 1
        RG 83852 monoclonal antibody: 1
        technetium Tc 99m CIBCNSH3: 1
        technetium Tc 99m-nofetumomab merpentan: 1
        TOL-101: 1
        9F7-F11 antibody
        AC12 monoclonal antibody
        EP-5C7 monoclonal antibody
        K7153A
        LBY135 monoclonal antibody
        M290SAP
        Mab13-1 monoclonal antibody
        monoclonal antibody 2P-1-2-1
        monoclonal antibody B23 heavy chain
        R21 monoclonal antibody
        RCK105
        RIME regimen
        technetium 99m rituximab
        technetium Tc 99m-monoclonal antibody-170H.82
        TSK114 monoclonal antibody
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Murine-Derived Monoclonal Antibodies: 1
        Rituximab: 15450
        Muromonab-CD3: 726
        Edrecolomab: 131
        anti-Fas monoclonal antibody: 49
        monoclonal antibody D2-40: 44
        Sulesomab: 38
        CT-P10: 29
        MOv18 monoclonal antibody: 28
        oregovomab: 28
        abagovomab: 22
        racotumomab: 18
        besilesomab: 9
        enlimomab: 8
        Lym-1 monoclonal antibody: 8
        8H9 monoclonal antibody: 7
        omburtamab I-131: 7
        3F8 antibody: 4
        64Cu-DOTA-rituximab: 4
        PR1A3 monoclonal antibody: 4
        12C3 monoclonal antibody: 3
        PF-06647263: 2
        23C3 monoclonal antibody: 1
        3D6 antibody: 1
        CD44 monoclonal antibody KMP1: 1
        MX 35 monoclonal antibody: 1
        RG 83852 monoclonal antibody: 1
        technetium Tc 99m CIBCNSH3: 1
        technetium Tc 99m-nofetumomab merpentan: 1
        TOL-101: 1
        9F7-F11 antibody
        AC12 monoclonal antibody
        EP-5C7 monoclonal antibody
        K7153A
        LBY135 monoclonal antibody
        M290SAP
        Mab13-1 monoclonal antibody
        monoclonal antibody 2P-1-2-1
        monoclonal antibody B23 heavy chain
        R21 monoclonal antibody
        RCK105
        RIME regimen
        technetium 99m rituximab
        technetium Tc 99m-monoclonal antibody-170H.82
        TSK114 monoclonal antibody

Experts

1.	Ahmadzadeh, Vahideh: 1 article (04/2014)
2.	Farajnia, Safar: 1 article (04/2014)
3.	Feizi, Mohammad Ali Hosseinpour: 1 article (04/2014)
4.	Nejad, Ramezan Ali Khavari: 1 article (04/2014)

Related Diseases

1.	Neoplasms (Cancer) 04/01/2014 - "However, the immunogenicity of murine-derived monoclonal antibodies is restrictive in cancer immunotherapy. "

Related Therapies and Procedures

1.	Immunotherapy